Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Oct 28, 2017; 23(40): 7321-7331
Published online Oct 28, 2017. doi: 10.3748/wjg.v23.i40.7321
Table 1 Demographic and clinical factors in patients with high, medium and low medication adherence n (%)
Demographic and clinical variablesAll patientsMedication adherence ranking
P value
HighMediumLow
(n = 42)(n = 37)(n = 21)
Age58.4 ± 10.257.9 ± 10.958.2 ± 9.057.8 ± 10.80.787
Male gender65 (65.0)21 (50.0)30 (81.1)14 (66.7)0.015
Primary aetiologyALD49 (48.0)19 (45.2)19 (51.4)11 (52.4)0.842
HCV35 (33.0)14 (33.3)13 (35.1)8 (38.1)0.963
Other16 (16.0)9 (21.5)5 (13.5)2 (9.5)0.383
1Child-Turcotte Pugh classA24 (24.0)6 (14.3)12 (32.4)6 (28.6)0.684
B59 (59.0)29 (69.0)21 (56.8)9 (42.8)
C17 (17.0)7 (16.7)4 (10.8)6 (28.6)
MELD score14.4 ± 5.214.6 ± 4.614.2 ± 5.114.2 ± 6.70.936
Ascites at review (incl. suppressed by medication)80 (80.0)37 (88.1)28 (75.7)15 (71.4)0.187
Encephalopathy at review (incl. suppressed by medication)36 (36.0)12 (28.6)13 (35.1)11 (52.4)0.184
Hepatocellular carcinoma8 (8.0)3 (7.1)3 (8.1)2 (9.5)1.00
Number of self-reported medicines7.1 ± 3.57.2 ± 3.77.1 ± 3.66.9 ± 3.10.923
Number of comorbidities5.5 ± 2.85.4 ± 2.85.8 ± 3.05.2 ± 2.50.703
2Unable to afford medicines19 (20.2)1 (2.5)12 (36.4)6 (28.6)< 0.001
3EducationNil, Primary, Middle school39 (42.4)14 (34.1)13 (43.3)12 (57.1)0.215
High school, Trade, University53 (57.6)27 (65.9)17 (56.7)9 (42.9)
4Employment statusEmployed18 (19.1)9 (22.0)6 (18.2)3 (14.3)0.842
Government welfare72 (76.6)30 (73.2)25 (75.8)18 (85.7)0.602
ARIAHighly accessible89 (89.0)36 (85.7)34 (91.9)19 (90.5)0.713
Accessible–remote11 (11.0)6 (14.3)3 (8.1)2 (9.5)
IRSDMost disadvantaged32 (32.0)16 (38.1)7 (18.9)9 (42.9)0.093
Low–moderate disadvantage68 (68.0)26 (68.9)30 (81.1)12 (57.1)